[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100617536":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":20,"centralContacts":26,"locations":31,"responsibleParty":103,"collaborators":105,"id":114,"slug":19,"hasResults":115,"nctId":116,"briefTitle":117,"officialTitle":118,"acronym":19,"eligibilityCriteria":119,"healthyVolunteers":120,"sex":121,"minAge":122,"maxAge":123,"enrollmentInfo":124,"targetDuration":19,"studyType":127,"phases":128,"briefSummary":131,"conditions":132,"keywords":136,"overallStatus":34,"whyStopped":19,"lastUpdateSubmitDate":142,"lastUpdatePostDateStruct":143,"startDateStruct":146,"completionDateStruct":148,"leadSponsor":150,"locationsCount":151},{"fullName":5,"class":6},"Peking University First Hospital","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"68Ga-BCMA PET\u002FCT","EXPERIMENTAL","Every patient will receive 68Ga-BCMA PET\u002FCT",[13],"Diagnostic Test: 68Ga-BCMA PET\u002FCT",[15],{"type":16,"name":9,"description":17,"armGroupLabels":18,"otherNames":19},"DIAGNOSTIC_TEST","Intravenous administration of the investigational BCMA-targeted radiopharmaceutical, followed by a whole-body PET\u002FCT scan performed per a standardized protocol.",[9],null,[21,24],{"name":22,"affiliation":5,"role":23},"Lei Kang, M.D, Ph.D","PRINCIPAL_INVESTIGATOR",{"name":25,"affiliation":5,"role":23},"Yujun Dong, M.D, Ph.D",[27],{"name":22,"role":28,"phone":29,"phoneExt":19,"email":30},"CONTACT","86+13811486428","kanglei@bjmu.edu.cn",[32,50,61,72,87],{"facility":33,"status":34,"city":35,"state":36,"zip":19,"country":37,"cosmosGeoPoint":38,"geoPoint":43,"contacts":44},"Beijing An Zhen Hospital of the Capital University of Medical Sciences","RECRUITING","Beijing","Beijing Municipality","China",{"type":39,"coordinates":40},"Point",[41,42],116.39723,39.9075,{"lat":42,"lon":41},[45,49],{"name":46,"role":28,"phone":47,"phoneExt":19,"email":48},"Yini Wang, M.D, Ph.D","8613901086559","wangyini@ccmu.edu.cn",{"name":46,"role":23,"phone":19,"phoneExt":19,"email":19},{"facility":51,"status":34,"city":35,"state":36,"zip":19,"country":37,"cosmosGeoPoint":52,"geoPoint":54,"contacts":55},"Beijing Tsinghua Changgung Hospital",{"type":39,"coordinates":53},[41,42],{"lat":42,"lon":41},[56,60],{"name":57,"role":28,"phone":58,"phoneExt":19,"email":59},"Lihong Li, M.D, Ph.D","86 135 0139 0152","llha03032@btch.edu.cn",{"name":57,"role":23,"phone":19,"phoneExt":19,"email":19},{"facility":5,"status":34,"city":35,"state":36,"zip":19,"country":37,"cosmosGeoPoint":62,"geoPoint":64,"contacts":65},{"type":39,"coordinates":63},[41,42],{"lat":42,"lon":41},[66,70,71],{"name":67,"role":28,"phone":68,"phoneExt":19,"email":69},"Tingfei Dr. Gu, M.D, Ph.D","8618513338311","tingfei.gu@ndm.ox.ac.uk",{"name":22,"role":23,"phone":19,"phoneExt":19,"email":19},{"name":25,"role":23,"phone":19,"phoneExt":19,"email":19},{"facility":73,"status":34,"city":74,"state":75,"zip":19,"country":37,"cosmosGeoPoint":76,"geoPoint":80,"contacts":81},"the Second Hospital of Hebei Medical University","Shijiazhuang","Hebei",{"type":39,"coordinates":77},[78,79],114.47861,38.04139,{"lat":79,"lon":78},[82,86],{"name":83,"role":28,"phone":84,"phoneExt":19,"email":85},"Fuxu Wang, M.D, Ph.D","8613931100360","wfxhebmu@163.com",{"name":83,"role":23,"phone":19,"phoneExt":19,"email":19},{"facility":88,"status":34,"city":89,"state":90,"zip":19,"country":37,"cosmosGeoPoint":91,"geoPoint":95,"contacts":96},"First Hospital of Jilin University","Jilin City","Jilin",{"type":39,"coordinates":92},[93,94],126.5608,43.84652,{"lat":94,"lon":93},[97,101],{"name":98,"role":28,"phone":99,"phoneExt":19,"email":100},"Fengyan Jing","8613844989638","fengyanjin@jlu.edu.cn",{"name":102,"role":23,"phone":19,"phoneExt":19,"email":19},"Fengyan Jing, M.D, Ph.D",{"type":104,"investigatorFullName":19,"investigatorTitle":19,"investigatorAffiliation":19,"oldNameTitle":19,"oldOrganization":19},"SPONSOR",[106,108,110,112],{"name":107,"class":6},"The First Hospital of Jilin University",{"name":109,"class":6},"The Second Hospital of Hebei Medical University",{"name":111,"class":6},"Beijing Anzhen Hospital",{"name":113,"class":6},"Beijing Tsinghua Changgeng Hospital","100617536",false,"NCT07319897","68Ga-BCMA PET\u002FCT in Multiple Myeloma","A Prospective, Multicenter, Diagnostic Study Evaluating 68Ga-BCMA PET\u002FCT for Targeting BCMA Expression in Multiple Myeloma.","Inclusion Criteria:\n\n* patients with suspected or previously diagnosed multiple myeloma (MM) who were scheduled for bone marrow aspiration or tissue biopsy within two weeks, including those undergoing initial diagnostic evaluation or follow-up\u002Fre-evaluation for disease monitoring or relapse;\n* patients with confirmed symptomatic MM;\n* ability to understand and voluntarily sign written informed consent;\n* ability to comply with study procedures;\n* Eastern Cooperative Oncology Group (ECOG) performance status ≤2.\n\nExclusion Criteria:\n\n* pregnancy or lactation;\n* inability to comprehend study procedures or cooperate with protocol requirements;\n* any other condition judged by the investigator to potentially interfere with study participation.",true,"ALL","18 Years","80 Years",{"count":125,"type":126},300,"ESTIMATED","INTERVENTIONAL",[129,130],"PHASE2","PHASE3","This is a prospective, multicenter diagnostic imaging study designed to evaluate the diagnostic accuracy and clinical utility of BCMA-targeted positron emission tomography\u002Fcomputed tomography (PET\u002FCT) in patients with multiple myeloma and related plasma cell disorders. The study aims to non-invasively visualize and quantify whole-body BCMA expression and to assess its role in the detection of active disease and disease heterogeneity.",[133,134,135],"Multiple Myeloma","Multiple Myeloma and Malignant Plasma Cell Neoplasms","Multiple Myeloma and Plasma Cell Neoplasm",[137,138,139,140,141],"multiple myeloma","bcma","PET\u002FCT","diagnosis","multicenter","2026-06-16",{"date":144,"type":145},"2026-06-22","ACTUAL",{"date":147,"type":145},"2025-12-25",{"date":149,"type":126},"2027-12-30",{"name":5,"class":6},5]